跳至主要内容
临床试验/IRCT138812102394N4
IRCT138812102394N4已完成3 期

Comparison of effects of ecosapentaenoic acid and docosahexaenoic acid on blood glucose, fat mass, MDA and C-reactive protein in patients with type 2 diabetes

Vice-chancellor for research, Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 65 years(—)
性别
All

入选标准

  • 1-Age: 35-65years;
  • 2-Willing to participate;
  • 3-Having diabetes type 2 for at least five years prior to entry;
  • 4-Blood sugar control with biguanide and sulfonylurea drugs for at least of one year prior to entry;
  • 5-Normal blood pressure and lipid profile;
  • 6-BMI : 20-35 kg/m2;
  • Exclusion criteria:
  • 1-Treatment with insulin;
  • 2-Taking fish oil supplements or NSAIDs during the last 3 months before intervention;
  • 3-Taking fish more than once a week;
  • 4-Having cardiovascular, liver, kidney disease;
  • 5-Smoking;
  • 6-Weight changes more than three kilograms during three months before intervention;
  • 7- Change in type or dose of oral hypoglycemic agent for at least two weeks prior to entry or during intervention;

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for research, Tehran University of Medical Sciences

相似试验